M Holdings Securities’s AbbVie ABBV Stock Holding History

M Holdings Securities’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,060	Closed	-$682K	–	197
2023 Q2	$682K	Sell	5,060 -14,652	-74%	-$2.15M	0.14%	91
2023 Q1	$3.14M	Buy	+19,712	New	+$3.01M	0.32%	57

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

M Holdings Securities's ABBV Position: Q2 2026 in Review

M Holdings Securities increased its AbbVie (ABBV) stake by 3.9% in Q2 2026, buying an estimated $191K and bringing the position to 23,422 shares worth $5.66M. The position accounts for 0.77% of the portfolio, ranked #23.

M Holdings Securities first reported a position in ABBV in Q4 2013 and has held it in 42 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

M Holdings Securities held 23,422 shares of AbbVie worth $5.66M as of Q2 2026.
M Holdings Securities bought 887 AbbVie shares in Q2 2026, an estimated $191K.
AbbVie made up 0.77% of M Holdings Securities's portfolio in Q2 2026, its #23 holding.
M Holdings Securities first reported a position in AbbVie in Q4 2013 and has held it in 42 quarters since.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on M Holdings Securities's 13F filing for Q2 2026, filed 11 Aug 2026.